Botulinum toxin A detrusor injections in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections

被引:90
作者
Game, Xavier [1 ]
Castel-Lacanal, Euelyne [2 ]
Bentaleb, Youssef [1 ]
Thiry-Escudie, Isabelle [2 ]
De Boissezon, Xavier [2 ]
Malavaud, Bernard [1 ]
Marque, Philippe [2 ]
Rischmann, Pascal [1 ]
机构
[1] CHU Rangueil, Serv Urol Androl & Transplantat Renale, F-31059 Toulouse, France
[2] CHU Rangueil, Serv Med Phys & Readaptat, F-31059 Toulouse, France
关键词
botulinurn toxin A; neurogenic bladder; neurourology; urinary infection;
D O I
10.1016/j.eururo.2007.08.039
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To study the effect of botulinum toxin A (BoNTA) injections into the detrusor muscle on the incidence of symptomatic urinary infections in patients with neurogenic detrusor overactivity. Methods: Between February 2004 and June 2005, 30 patients (18 men, 12 women), mean age 39.4+/-12.1 yr, with neurogenic detrusor overactivity received an injection of 300 U Botox(R) (Allergan Inc., Irvine, CA, USA) into the detrusor. Fifteen patients had multiple sclerosis, 14 had spinal cord injury, and I had myelitis. Twenty-two patients had urinary incontinence. Patients were either resistant to anticholinergic medications, had discontinued treatment because of adverse effects, or had contraindications to anticholinergic drugs. Before and 6 wk after injection, each patient kept a bladder diary and underwent urodynamic investigation, retrograde and voiding cystourethrography, and urine culture. All symptomatic urinary infections (pyelonephritis, orchitis, prostatitis) occurring in the 6 mo before and the 6 mo after injection were recorded. Results: Before injection, the mean number of symptomatic urinary infections over 6 mo was 1.75+/-1.87. After injection, the mean was 0.2+/-0.41 (p = 0.003), and only 3 patients presented symptomatic urinary infections. These patients were those who showed less improvement in their urodynamic parameters after injection (volume of the first uninhibited contraction, maximum bladder pressure, and maximum cystometric capacity, respectively; p = 0.0037, p = 0.0002, p = 0.0027, ANOVA). Conclusions: BoNTA injections into the detrusor muscle significantly decreased the incidence of symptomatic urinary infections. This effect seems to be related to improvement in urodynamic parameters, reflecting improved reservoir capacity at low pressure. (C) 2007 European Association of Urology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:613 / 619
页数:7
相关论文
共 33 条
[1]   Anticholinergic drugs versus non-drug active therapies for overactive bladder syndrome in adults [J].
Alhasso, A. A. ;
McKinlay, J. ;
Patrick, K. ;
Stewart, L. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (04)
[2]  
[Anonymous], 1992, J Am Paraplegia Soc, V15, P194, DOI [10.1080/01952307.1992.11735873, DOI 10.1080/01952307.1992.11735873]
[3]   Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity [J].
Apostolidis, A ;
Dasgupta, P ;
Fowler, CJ .
EUROPEAN UROLOGY, 2006, 49 (04) :644-650
[4]   CLINICAL-SIGNIFICANCE OF URETERIC DIAMETER ON INTRAVENOUS UROGRAPHY AFTER SPINAL-CORD INJURY [J].
ARNOLD, EP ;
COWAN, IA .
BRITISH JOURNAL OF UROLOGY, 1988, 62 (02) :131-135
[5]   Etiology and incidence of rehospitalization after traumatic spinal cord injury: A multicenter analysis [J].
Cardenas, DD ;
Hoffman, JM ;
Kirshblum, S ;
McKinley, W .
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2004, 85 (11) :1757-1763
[6]   Subcutaneous administration of botulinum toxin A reduces formalin-induced pain [J].
Cui, ML ;
Khanijou, S ;
Rubino, J ;
Aoki, KR .
PAIN, 2004, 107 (1-2) :125-133
[7]   Epidemiology and risk factors for urinary tract infection in patients with spinal cord injury [J].
De Ruz, AE ;
Leoni, EG ;
Cabrera, RH .
JOURNAL OF UROLOGY, 2000, 164 (04) :1285-1289
[8]  
De Seze M, 2006, PELVI-PERINEOLOGIE, V1, P77
[9]   Improving the global management of the neurogenic bladder patient: part II. Future treatment strategies [J].
Denys, Pierre ;
Corcos, Jacques ;
Everaert, Karel ;
Chartier-Kastler, Emmanuel ;
Fowler, Clare ;
Kalsi, Vinay ;
Nitti, Victor ;
Schulte-Baukloh, Heinrich ;
Schurch, Brigitte .
CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (05) :851-860
[10]  
DITUNNO JF, 1994, PARAPLEGIA, V32, P70, DOI 10.1038/sc.1994.13